vs

Side-by-side financial comparison of Abbott Laboratories (ABT) and Adobe Inc. (ADBE). Click either name above to swap in a different company.

Abbott Laboratories is the larger business by last-quarter revenue ($11.5B vs $6.4B, roughly 1.8× Adobe Inc.). Adobe Inc. runs the higher net margin — 29.5% vs 15.5%, a 14.0% gap on every dollar of revenue. On growth, Adobe Inc. posted the faster year-over-year revenue change (12.0% vs 4.4%). Adobe Inc. produced more free cash flow last quarter ($2.9B vs $2.6B). Over the past eight quarters, Adobe Inc.'s revenue compounded faster (9.8% CAGR vs 7.2%).

Abbott Laboratories, commonly known as Abbott, is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois. The company produces pharmaceuticals for sale outside the United States, diagnostic products, nutritional products, and medical devices.

Adobe Inc., formerly Adobe Systems Incorporated, is an American multinational computer software company based in San Jose, California. It offers a wide range of programs from web design tools, photo manipulation, and vector creation to video and audio editing, mobile app development, print layout, and animation software.

ABT vs ADBE — Head-to-Head

Bigger by revenue
ABT
ABT
1.8× larger
ABT
$11.5B
$6.4B
ADBE
Growing faster (revenue YoY)
ADBE
ADBE
+7.6% gap
ADBE
12.0%
4.4%
ABT
Higher net margin
ADBE
ADBE
14.0% more per $
ADBE
29.5%
15.5%
ABT
More free cash flow
ADBE
ADBE
$295.0M more FCF
ADBE
$2.9B
$2.6B
ABT
Faster 2-yr revenue CAGR
ADBE
ADBE
Annualised
ADBE
9.8%
7.2%
ABT

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
ABT
ABT
ADBE
ADBE
Revenue
$11.5B
$6.4B
Net Profit
$1.8B
$1.9B
Gross Margin
57.0%
89.6%
Operating Margin
19.6%
37.8%
Net Margin
15.5%
29.5%
Revenue YoY
4.4%
12.0%
Net Profit YoY
-80.8%
4.3%
EPS (diluted)
$1.01
$4.60

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ABT
ABT
ADBE
ADBE
Q1 26
$6.4B
Q4 25
$11.5B
$6.2B
Q3 25
$11.4B
$6.0B
Q2 25
$11.1B
$5.9B
Q1 25
$10.4B
$5.7B
Q4 24
$11.0B
$5.6B
Q3 24
$10.6B
$5.4B
Q2 24
$10.4B
$5.3B
Net Profit
ABT
ABT
ADBE
ADBE
Q1 26
$1.9B
Q4 25
$1.8B
$1.9B
Q3 25
$1.6B
$1.8B
Q2 25
$1.8B
$1.7B
Q1 25
$1.3B
$1.8B
Q4 24
$9.2B
$1.7B
Q3 24
$1.6B
$1.7B
Q2 24
$1.3B
$1.6B
Gross Margin
ABT
ABT
ADBE
ADBE
Q1 26
89.6%
Q4 25
57.0%
89.5%
Q3 25
55.4%
89.3%
Q2 25
56.4%
89.1%
Q1 25
56.9%
89.1%
Q4 24
55.0%
89.0%
Q3 24
55.8%
89.8%
Q2 24
55.6%
88.7%
Operating Margin
ABT
ABT
ADBE
ADBE
Q1 26
37.8%
Q4 25
19.6%
36.5%
Q3 25
18.1%
36.3%
Q2 25
18.4%
35.9%
Q1 25
16.3%
37.9%
Q4 24
17.4%
34.9%
Q3 24
17.5%
36.8%
Q2 24
16.1%
35.5%
Net Margin
ABT
ABT
ADBE
ADBE
Q1 26
29.5%
Q4 25
15.5%
30.0%
Q3 25
14.5%
29.6%
Q2 25
16.0%
28.8%
Q1 25
12.8%
31.7%
Q4 24
84.1%
30.0%
Q3 24
15.5%
31.1%
Q2 24
12.5%
29.6%
EPS (diluted)
ABT
ABT
ADBE
ADBE
Q1 26
$4.60
Q4 25
$1.01
$4.44
Q3 25
$0.94
$4.18
Q2 25
$1.01
$3.94
Q1 25
$0.76
$4.14
Q4 24
$5.26
$3.75
Q3 24
$0.94
$3.76
Q2 24
$0.74
$3.49

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ABT
ABT
ADBE
ADBE
Cash + ST InvestmentsLiquidity on hand
$8.9B
$6.9B
Total DebtLower is stronger
$12.9B
$5.4B
Stockholders' EquityBook value
$52.1B
$11.4B
Total Assets
$86.7B
$29.7B
Debt / EquityLower = less leverage
0.25×
0.47×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ABT
ABT
ADBE
ADBE
Q1 26
$6.9B
Q4 25
$8.9B
$6.6B
Q3 25
$7.7B
$5.9B
Q2 25
$7.3B
$5.7B
Q1 25
$6.8B
$7.4B
Q4 24
$8.0B
$7.9B
Q3 24
$7.8B
$7.5B
Q2 24
$7.2B
$8.1B
Total Debt
ABT
ABT
ADBE
ADBE
Q1 26
$5.4B
Q4 25
$12.9B
$6.2B
Q3 25
$6.2B
Q2 25
$6.2B
Q1 25
$6.2B
Q4 24
$14.1B
$4.1B
Q3 24
$4.1B
Q2 24
$4.1B
Stockholders' Equity
ABT
ABT
ADBE
ADBE
Q1 26
$11.4B
Q4 25
$52.1B
$11.6B
Q3 25
$51.0B
$11.8B
Q2 25
$50.6B
$11.4B
Q1 25
$48.8B
$13.1B
Q4 24
$47.7B
$14.1B
Q3 24
$39.8B
$14.5B
Q2 24
$39.3B
$14.8B
Total Assets
ABT
ABT
ADBE
ADBE
Q1 26
$29.7B
Q4 25
$86.7B
$29.5B
Q3 25
$84.2B
$28.8B
Q2 25
$84.0B
$28.1B
Q1 25
$81.4B
$30.0B
Q4 24
$81.4B
$30.2B
Q3 24
$74.4B
$29.8B
Q2 24
$73.0B
$30.0B
Debt / Equity
ABT
ABT
ADBE
ADBE
Q1 26
0.47×
Q4 25
0.25×
0.53×
Q3 25
0.53×
Q2 25
0.54×
Q1 25
0.47×
Q4 24
0.30×
0.29×
Q3 24
0.28×
Q2 24
0.28×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ABT
ABT
ADBE
ADBE
Operating Cash FlowLast quarter
$3.3B
$3.0B
Free Cash FlowOCF − Capex
$2.6B
$2.9B
FCF MarginFCF / Revenue
22.9%
45.7%
Capex IntensityCapex / Revenue
6.0%
0.6%
Cash ConversionOCF / Net Profit
1.87×
1.57×
TTM Free Cash FlowTrailing 4 quarters
$7.4B
$10.3B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ABT
ABT
ADBE
ADBE
Q1 26
$3.0B
Q4 25
$3.3B
$3.2B
Q3 25
$2.8B
$2.2B
Q2 25
$2.0B
$2.2B
Q1 25
$1.4B
$2.5B
Q4 24
$2.9B
Q3 24
$2.7B
$2.0B
Q2 24
$2.0B
$1.9B
Free Cash Flow
ABT
ABT
ADBE
ADBE
Q1 26
$2.9B
Q4 25
$2.6B
$3.1B
Q3 25
$2.3B
$2.1B
Q2 25
$1.5B
$2.1B
Q1 25
$933.0M
$2.5B
Q4 24
$2.1B
Q3 24
$2.1B
$2.0B
Q2 24
$1.4B
$1.9B
FCF Margin
ABT
ABT
ADBE
ADBE
Q1 26
45.7%
Q4 25
22.9%
50.5%
Q3 25
20.2%
35.5%
Q2 25
13.9%
36.5%
Q1 25
9.0%
43.0%
Q4 24
19.6%
Q3 24
20.2%
36.3%
Q2 24
13.8%
35.8%
Capex Intensity
ABT
ABT
ADBE
ADBE
Q1 26
0.6%
Q4 25
6.0%
0.5%
Q3 25
4.4%
1.2%
Q2 25
4.5%
0.8%
Q1 25
4.7%
0.5%
Q4 24
6.6%
Q3 24
5.2%
1.1%
Q2 24
5.1%
0.8%
Cash Conversion
ABT
ABT
ADBE
ADBE
Q1 26
1.57×
Q4 25
1.87×
1.70×
Q3 25
1.70×
1.24×
Q2 25
1.15×
1.30×
Q1 25
1.07×
1.37×
Q4 24
0.31×
Q3 24
1.64×
1.20×
Q2 24
1.51×
1.23×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ABT
ABT

Segment breakdown not available.

ADBE
ADBE

Subscription Revenue$6.2B97%
Service Other$110.0M2%
Products$90.0M1%

Related Comparisons